GNTA vs NP5: Side-by-Side Comparison
Compare Genenta Science SpA (GNTA) and NEWRON PHARMACEUT. EO-20 (NP5) side by side: market cap USD 40.58M vs EUR 281.92M. Financials, growth and model signals on Bullrun.
| Metric | GNTA | NP5 |
|---|---|---|
| Company | Genenta Science SpA | NEWRON PHARMACEUT. EO-20 |
| Country / Exchange | Italy · NASDAQ | Italy · XETRA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | USD 40.58M | EUR 281.92M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | — | EUR 19.13M |
| Revenue growth YoY | — | -62.8% |
| Net income | — | EUR -13.24M |
| Gross margin | — | — |
| Diluted EPS | — | -0.66 |